TPO is removed from circulation through MPL (myeloproliferative leukemia protein)-mediated internalization and degradation in platelets; therefore, thrombocytopenia in AA determines reduced TPO clearance from peripheral blood, leading to increased circulating levels of this growth factor [46,47,48,49]. This evidence concerns the gene MPL and Thrombocytopenia.